Market Reports, Financial Report

Suryavanshi Spinning Mills Limited

Published on 
Author: SAMRUDDHI DALVI
Suryavanshi Spinning Mills Limited
  1. Introduction

Suryavanshi Spinning Mills Limited (SSML), a company undergoing a major structural transformation, offers a unique perspective on the broader changes reshaping the Indian textile industry. The traditional spinning model has been under extreme pressure, despite the industry's steady 2.3% GDP contribution.

On the other hand, for those brave enough to change course, the Medical Textiles market, which is expected to grow to $1,795.2 million by 2028, offers a high-growth frontier.

This analysis evaluates whether SSML's strategic exit from its core operations holds financial water. Looking at its 46-year history, one cannot ignore the fact that the company has reached a definitive crossroad between legacy insolvency and technical textile viability.

2. Company Overview

When traditional business segments become operationally unviable, evolution is the only alternative to extinction. SSML, incorporated in 1978, has navigated away from its heritage in yarn and garments toward high-value "Bleached Cotton" for medical, cosmetic, and defense applications.

A critical strategic asset in this transition is SSML’s status as a Government Recognised Export House. The Aliabad manufacturing facility in Telangana now serves as the heartbeat of the pivot. This isn't just a product change; it’s a strategic bet on a niche requiring specific certifications that legacy competitors lack.

The success of this rebirth rests entirely on the leadership currently steering the ship through these choppy waters.

3. Promoter / Founder Introduction

In family-led Indian enterprises, "Promoter Skin in the Game" is often the most reliable indicator of survival instinct. At SSML, this rests with Mr. Rajender Kumar Agarwal, Managing Director and CFO. A mechanical engineer with over 25 years of expertise, Mr. Agarwal navigated the company through the high-stakes discontinuation of the spinning division on November 1, 2023. His decision to halt cash-hemorrhaging legacy operations signaled a shift from growth-at-all-costs to a survival-first mentality.

Management’s choices are directly reflected in the recent financial volatility, mirroring the "all-in" approach required for a corporate turnaround.

4. Financial Statement Analysis

One must view these figures as a "restarting" phase. The numbers reflect a company stripping itself down to its chassis.


Particulars

FY 2024-25

FY 2023-24

FY 2022-23

Revenue from Operations

111.19

65.68

140.00

Other Income

171.78

155.82

91.00

Net Profit / (Loss)

(167.89)

144.71

(23.00)

Total Assets

1,801.12

2,554.28

3,607.00

Financial Statement Analysis
 Financial Statement Analysis




Income & Governance Interpretations

Looking at the records, revenue grew 69% year-over-year as the medical wing scaled, yet the net loss of ₹167.89L persists. The "So What?" is clear: survival is currently propped up by the liquidation of non-core assets (reflected in the ₹171.78L Other Income).

More concerning is the auditor’s report regarding corporate governance. One cannot overlook the Section 186 non-compliance involving interest-free loans to related parties. For a senior analyst, this is a major red flag that offsets the operational discipline seen in the improvement of debtor days from 257 to 128.

Revenue Trends (INR Lakhs)

5. Key Insights & Interpretation

A turnaround firm like SSML requires us to look for hidden moats rather than just current P&L.

  • Strengths: Export House status and a niche focus on Defense/Medical cotton. Improved debtor management suggests tighter internal controls.
  • Weaknesses: Chronic accumulated losses (Reserves at -₹1,481.65L) and auditor qualifications regarding ₹226.08L in trade payables and related-party loan documentation.
  • Risk Factors: High dependency on "Other Income" from asset sales to offset operational losses and volatility in raw cotton prices.
  • Outlook: If SSML can resolve its liquidity constraints and governance issues, the Aliabad facility could scale.

6. Conclusion

Suryavanshi Spinning Mills' financial situation is "Critical but Stabilising." Although the strategic shift is sound, it is impossible to ignore the governance red flags. With a market cap of roughly ₹9 Crores, the company is a speculative play on the successful scaling of medical textiles and the final liquidation of legacy liabilities.

Source: 46th Annual Report (2024-25) of Suryavanshi Spinning Mills Limited and BSE/Screener Financial Filings.


Subscribe to our Weekly E-Newsletter

Stay updated with the latest news, articles, and market reports, appointments, many more.

By subscribing you agree to our Terms and Privacy Policy.